Retrospective analysis of human papillomavirus prevalence in women with cervical pathology

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: This study aimed to compare the distribution of different human papillomavirus (HPV) genotypes in various cervical lesions and estimate the prevalence of low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL) when one or more HPV genotypes are detected.

Materials and methods: We conducted an analysis of HPV testing using the Quantum-21 test system in 19236 women aged 18–81 years who visited the V.I. Kulakov NMRC for OG&P between November 2011 and April 2022. Among these women, 5700 tested positive for HPV and were included in this analysis. We retrospectively examined the laboratory findings used to confirm this diagnosis. The patients were divided into three groups based on the histological verification of the diagnosis. Group 1 included 186 patients with chronic cervicitis, Group 2 included 341 patients with LSIL, and Group 3 included 292 patients with HSIL.

Results: Analysis of HPV genotype distribution revealed that HPV type 16 was the most prevalent (23.6%), followed by genotypes 44 (12.3%), and 31 (12.3%). The evaluation of HPV genotype prevalence showed that in 66.6% of cases, only one HPV type was detected, whereas in 20.8% of cases, two types were detected. Three types were found in 7.4% of cases and four or more types were detected in 5.2% of cases. Examination of the ratio between single and multiple HPV types revealed that the detection of multiple genotypes was significantly more frequently associated with LSIL than with HSIL (24.9% vs. 5.5%, respectively).

Conclusion: The results of this study demonstrated that the distribution and representation of HPV genotypes in cervical pathology in our sample differed from global trends. Furthermore, the study showed that the detection rate of multiple HPV types decreased with increasing grades of cervical lesions.

 

Full Text

Restricted Access

About the authors

Alexander O. Andreev

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: sasha.grash2010@yandex.ru
ORCID iD: 0000-0002-9835-440X

Ph.D. Student

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Guldana R. Bayramova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: bayramova@mail.ru
ORCID iD: 0000-0003-4826-661X

Dr. Med. Sci., Merited Doctor of the Russian Federation, Professor at the Department of Obstetrics and Gynecology of the Department of Professional Education

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Natalya A. Ilyasova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: natalia_ilyasova@mail.ru
ORCID iD: 0000-0003-0665-3515

Researcher at the Department of International Cooperation, Obstetrician-Gynecologist at the Research and Outpatient Department

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Alexandra V. Asaturova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: a_asaturova@oparina4.ru
ORCID iD: 0000-0001-8739-5209

Dr. Med. Sci., Head of the 1st Anatomic Pathology Department

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Dmitry Yu. Trofimov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: d_trofimov@oparina4.ru

Corresponding Member of the RAS, Professor, Dr. Bio. Sci., Director of the Institute of Reproductive Genetics

 

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

References

  1. Nelson C.W., Mirabello L. Human papillomavirus genomics: Understanding carcinogenicity. Tumour Virus Res. 2023;15:200258. https://dx.doi.org/10.1016/10.1016/j.tvr.2023.200258.
  2. Sun J.X., Xu J.Z., Liu C.Q., An Y., Xu M.Y., Zhong X.Y. et al. The association between human papillomavirus and bladder cancer: Evidence from meta-analysis and two-sample mendelian randomization. J. Med. Virol. 2023; 95(1): e28208. https://dx.doi.org/10.1002/jmv.28208.
  3. Добровольская Д.А., Байрамова Г.Р., Асатурова А.В., Теврюкова Н.С. Прогностическая значимость биомаркеров вируса папилломы человека в дифференциальной диагностике плоскоклеточных интраэпителиальных поражений шейки матки. Акушерство и гинекология. 2022;6:20-5. [Dobrovolskaya D.A., Bairamova G.R., Asaturova A.V., Tevryukova N.S. Prognostic value of human papillomavirus biomarkers in the differential diagnosis of squamous intraepithelial lesions of the cervix. Obstetrics and Gynecology. 2022;(6):20-5. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.6.20-25.
  4. Bedell S.L., Goldstein L.S., Goldstein A.R., Goldstein A.T. Cervical cancer screening: past, present, and future. Sex Med. Rev. 2020;8(1):28-37. https://dx.doi.org/10.1016/j.sxmr.2019.09.005.
  5. Lee J.E., Chung Y., Rhee S., Kim T.H. Untold story of human cervical cancers: HPV-negative cervical cancer. BMB Rep. 2022;55(9):429-38. https://dx.doi.org/10.5483/BMBRep.2022.55.9.042.
  6. National Institute of Allergy and Infectious Diseases. PaVE: the papillomavirus episteme. Release Note, 19 May 2023. https://pave.niaid.nih.gov/release_notes
  7. Министерство здравоохранения Российской Федерации. Клинические рекомендации «Цервикальная интраэпителиальная неоплазия, эрозия и эктропион шейки матки». 2020. [Ministry of Health of the Russian Federation. Clinical guidelines "Cervical intraepithelial neoplasia, erosion and ectropion of the cervix". 2020. (in Russian)].
  8. Farahmand M., Moghoofei M., Dorost A., Abbasi S., Monavari S.H., KianiS.J., Tavakoli A. Prevalence and genotype distribution of genital human papillomavirus infection in female sex workers in the world: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):1455. https://dx.doi.org/10.1186/s12889-020-09570-z.
  9. Yang X., Li Y., Tang Y., Li Z., Wang S., Luo X. et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg. Microbes Infect. 2023; 12(1):e2176009. https://dx.doi.org/ 10.1080/22221751.2023.2176009.
  10. Derbie A., Mekonnen D., Yismaw G., Biadglegne F., Van Ostade X., Abebe T. Human papillomavirus in Ethiopia. Virusdisease. 2019;30(2):171-9. https://dx.doi.org/10.1007/s13337-019-00527-4.
  11. Yang-Chun F., Yuan Z., Cheng-Ming L., Yan-Chun H., Xiu-Min M. Increased HPV L1 gene methylation and multiple infection status lead to the difference of cervical epithelial cell lesion in different ethnic women of Xinjiang, China. Medicine (Baltimore). 2017;96(12):e6409. https://dx.doi.org/10.1097/MD.0000000000006409.
  12. Kim M., Park N.J., Jeong J.Y., Park J.Y. Multiple human papilloma virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients. Viruses. 2021;13(7):1342. https://dx.doi.org/10.3390/v13071342.
  13. Bruno M.T., Scalia G., Cassaro N., Boemi S. Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression. BMC Cancer. 2020; 20(1):444. https://dx.doi.org/10.1186/s12885-020-06946-7.
  14. Wang X., Zeng Y., Huang X., Zhang Y. Prevalence and genotype distribution of human papillomavirus in invasive cervical cancer, cervical intraepithelial neoplasia, and asymptomatic women in Southeast China. Biomed. Res. Int. 2018;2018:2897937. https://dx.doi.org/10.1155/2018/ 2897937.
  15. Xia C., Li S., Long T., Chen Z., Chan P.K.S., Boon S.S. Current updates on cancer-causing types of human papillomaviruses (HPVs) in East, Southeast, and South Asia. Cancers (Basel). 2021;13(11):2691. https://dx.doi.org/10.3390/cancers13112691.
  16. Zhang J., Cheng K., Wang Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis. Arch Gynecol Obstet. 2020;302(6):1329-37. https://dx.doi.org/10.1007/ s00404-020-05787-w.
  17. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021:71(3):209-49. 10.3322/caac.21660' target='_blank'>https://dx.doi.org/doi: 10.3322/caac.21660.
  18. Inturrisi F., Bogaards J.A., Heideman D.A.M., Meijer C.J.L.M., Berkhof J. Risk of cervical intraepithelial neoplasia grade 3 or worse in HPV-positive women with normal cytology and five-year type concordance: a randomized comparison. Cancer Epidemiol. Biomarkers Prev. 2021; 30(3):485-91. https://dx.doi.org/10.1158/1055-9965.
  19. Костава М.Н. ВПЧ-ассоциированные заболевания в вопросах и ответах. Акушерство и гинекология. 2021; 11: 267-76. [Kostava M.N. HPV-associated diseases: questions and answers. Obstetrics and Gynecology. 2021;(11):267-76. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.11.267-276.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig.1.

Download (65KB)
3. Fig.2.

Download (85KB)
4. Fig.3.

Download (65KB)
5. Fig.4.

Download (71KB)
6. Fig.5.

Download (66KB)
7. Fig.6.

Download (98KB)
8. Fig.7.

Download (177KB)

Copyright (c) 2023 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies